Navigation Links
Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme
Date:12/7/2007

es.

About Orphan Drug Designation

Orphan drug designation grants special status to promising new therapies that treat rare diseases or conditions affecting fewer than 200,000 people in the United States and entitles seven years of market exclusivity. Additionally, the sponsor of the product is offered incentives which include eligibility for research grants, certain tax benefits, protocol assistance and possible exemptions or reductions of certain regulatory fees during development or at a time of market approval.

About Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc. is a biotechnology company focused on developing therapeutic vaccines that target and stimulate the body's immune system for the treatment of cancer, infectious and autoimmune diseases. Celldex has three product candidates already in or about to enter clinical development targeting multiple cancers and Hepatitis B. Four additional product candidates are in preclinical development for cancer and autoimmune disease. Celldex's proprietary technology platform uses fully human monoclonal antibodies administered directly to patients to target and stimulate dendritic cells - key cells within the immune system. The Company is headquartered in Phillipsburg, New Jersey. On October 22, 2007, Celldex and AVANT Immunotherapeutics, Inc. announced that they had signed a definitive merger agreement. The all-stock transaction, approved by both companies' Boards of Directors, will combine Celldex and Avant. Closing of the merger is contingent upon a vote of approval by the current stockholders of AVANT at a special meeting expected to take place in the first quarter 2008. For more information, please visit the website: http://www.celldextherapeutics.com.

Additional Information about the Merger and Where to Find It

This communication contains "forward-looking" statements within the meaning of the Private Securiti
'/>"/>

SOURCE Celldex Therapeutics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... -- Paragon 28, Inc . announced ... foot plating system that supplants the Normed product line ... R3CON PLATING SYSTEM greatly enhances the product offerings of ... TM Screw Systems and Preserve TM Bone ... the GORILLA TM R3CON SYSTEM offers innovative solutions ...
(Date:9/22/2014)... 2014 Avanir Pharmaceuticals, Inc. (NASDAQ: ... sell $200 million of its common stock in an ... BofA Merrill Lynch are acting as joint book-running managers ... 30-day option to purchase additional shares of its common ... the offering are being sold by Avanir.  The offering ...
(Date:9/22/2014)... 2014 The western European automated endoscope ... largely a replacement market with fewer new installations ... and partnerships are redefining competitive landscape in western ... provides details about revenue forecasts, unit shipments, market ... the country. The changing landscape makes it important ...
Breaking Medicine Technology:Paragon 28, Inc. Launches the GORILLA(TM) R3CON PLATING SYSTEM 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 3Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3
...  Merrimack Pharmaceuticals, Inc. announced today that the first ... clinical study combining MM-121, a fully human monoclonal ... irinotecan (Camptosar®) in patients with advanced cancers. ... The Phase 1 study evaluates the safety and ...
... Md., Dec. 13, 2011 The U.S. Food and ... device intended to aid in the detection of life-threatening ... spectroscopy. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... health care providers identify patients with critical head injuries ...
Cached Medicine Technology:Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121 in Combination with Cetuximab and Irinotecan in Patients with Advanced Cancers 2FDA Permits Marketing of the First Hand-Held Device To Aid in the Detection of Bleeding In The Skull 2FDA Permits Marketing of the First Hand-Held Device To Aid in the Detection of Bleeding In The Skull 3
(Date:9/22/2014)... 2014 The Philadelphia 100, which honors ... region each year, is considered a hallmark of entrepreneurship ... Precision is proud to announce it has earned a ... will attend the Philadelphia 100 awards banquet ... business events of the year, as well as a ...
(Date:9/22/2014)... Thursdays to Sundays are when people both exercise more ... daily alcohol intake and physical activity , Findings differ ... CHICAGO --- A new Northwestern Medicine study finds that ... to Sundays -- they drink more alcohol, too. , ... and a daily diary approach for self-reporting physical activity ...
(Date:9/22/2014)... Los Angeles, CA (PRWEB) September 22, 2014 ... the life insurance industry is now easier using the ... adults who are trying to local universal life insurance ... , The adult coverage plans that are easily viewed ... companies that underwrite specific lengths of coverage. The plan ...
(Date:9/22/2014)... 22, 2014 (HealthDay News) -- Teens and young adults ... behavioral counseling to help prevent risky sexual behaviors, according ... Force. Every year, about 20 million new sexually ... the United States. About half involve people between 15 ... Its new report, published Sept. 22 in ...
(Date:9/22/2014)... -- All sexually active women should be screened ... infections: chlamydia and gonorrhea, according to new recommendations ... The task force noted this recommendation includes ... age and pregnant women. Most women with ... a result, many infections go undetected. If left ...
Breaking Medicine News(10 mins):Health News:MK Precision Announces Spot on Philadelphia 100 Fastest Growing Companies 2Health News:We drink more alcohol on gym days 2Health News:Universal Life Insurance Prices for Adults Added to National Insurer Portal Online 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 3Health News:Screen Women for Chlamydia, Gonorrhea, Experts Say 2
... of Children,s Health indicates 31 percent of Missouri children ... activity requirements for students and nutritional standards for school ... study from the University of Missouri shows Jump Into ... in changing unhealthy youth behaviors. JIA aims to ...
... Ltd., a medical device company publicly traded on the ... European Journal of Heart Failure, a peer reviewed ... the results of a 72-patients, randomized, controlled study which ... the home setting can significantly relieve symptoms of heart ...
... , Scientists at the University of Granada have ... pregnant women may be a factor associated with spontaneous abortion, a ... never been proven in humans before. For the purpose of ... 265 women, 132 had suffered a spontaneous miscarriage during that year. ...
... have long been an attractive class of drug candidates ... fewer potential side effects. Dr. Andrei Yudin, Professor, ... new and effective process that makes linear peptides circular, ... more effectively and increase their stability compared to linear ...
... that mutate to resist drug treatment survive by establishing tiny ... penetrate the cell membrane making the cancer insensitive to ... a new way to break that resistance and shut off ... forcibly activate a heat-shock protein called Hsp27. This protein regulates ...
... Sept. 28 (HealthDay News) -- Just like extremely premature babies, ... impaired lung function at ages 8 to 9, but in ... time they are teenagers, research shows. "There has been ... premature birth can have on the lung function of children, ...
Cached Medicine News:Health News:Students 'jump into action' for better health 2Health News:European Journal of Heart Failure publishes new randomized controlled clinical study of RESPeRATE 2Health News:Low zinc and copper levels might cause spontaneous abortion 2Health News:Low zinc and copper levels might cause spontaneous abortion 3Health News:OGI and MaRS Innovation invest in peptide therapeutics 2Health News:Scientists shut down pump action to break breast cancer cells' drug resistance 2Health News:Scientists shut down pump action to break breast cancer cells' drug resistance 3Health News:Lung Function of Late Preemies May Improve With Age 2
Ready to use liquid single reagent for automated chemistry analyzers. Linearity to 1000 mmol/L...
The Proteineer suite integrates powerful mass spectrometers with robotics and bioinformatics to deliver maximum productivity in high-throughput proteomics....
The ProteomeLab PA 800 resolves and quantifies proteins by their isoelectric point and molecular weight, generates high-resolution peptide maps and carbohydrate profiles and provides front-end separa...
Storage temperature: 2 - 8C, linearity: 0 - 700 mg/dL, expected values: 30 - 780 mg/dL. Available with calibrator and number of tests 110....
Medicine Products: